04640nam 2200613Ia 450 991014322750332120230617024657.01-280-27403-497866102740310-470-87142-30-470-87143-1(CKB)111087027097508(EBL)219722(OCoLC)53915007(SSID)ssj0000138993(PQKBManifestationID)11158846(PQKBTitleCode)TC0000138993(PQKBWorkID)10106918(PQKB)10648929(MiAaPQ)EBC219722(EXLCZ)9911108702709750820030410d2003 uy 0engur|n|---|||||txtccrDigital audio broadcasting[electronic resource] principles and applications of digital radio2nd ed.Chichester Wiley20031 online resource (361 p.)Previous ed.: 2001.0-470-85013-2 Includes bibliographical references (p. [309]-322) and index.Digital Audio Broadcasting; Contents; Foreword; Preface; List of contributors; Abbreviations; 1 Introduction; 1.1 General; 1.2 Radio in the Digital Age; 1.3 Benefits of the Eureka 147 DAB System; 1.4 History of the Origins of DAB; 1.5 International Standardisation; 1.6 Relations to Other Digital Broadcasting Systems; 2 System Concept; 2.1 The Physical Channel; 2.2 The DAB Transmission System; 2.3 The DAB Multiplex; 2.4 Conditional Access; 2.5 Service Information; 3 Audio Services and Applications; 3.1 General; 3.2 Audio Coding; 3.3 Characteristics and Features of MPEG-1 Layer II for DAB3.4 Programme-associated Data3.5 Advanced Audio Applications Using MPEG-2 Features; 3.6 Quality of Service; 3.7 Error Protection and Concealment; 3.8 A Typical DAB Ensemble; 3.9 Audio Levels; 4 Data Services and Applications; 4.1 General; 4.2 Data Service Signalling; 4.3 Multimedia Applications with MOT; 4.4 Standardised MOT User Application; 4.5 ""Mobil-Info"" as an Example of a Proprietary MOT User Application; 4.6 Textual PAD Services; 4.7 Traffic Information Services and Navigation Aids; 4.8 Moving Picture Services; 4.9 Other Data Transmission Mechanism; 5 Provision of Services5.1 The DAB Service Landscape5.2 Use of Existing Infrastructures; 5.3 Need for New Infrastructure; 5.4 Relationship between DAB Data Services and RDS; 5.5 Electronic Programme Guide (EPG) for DAB; 5.6 Possible New Audio Services; 6 Collection and Distribution Networks; 6.1 General; 6.2 The Collection Network; 6.3 The Distribution Network; 6.4 Example of Implementation; 7 The Broadcast Side; 7.1 General; 7.2 Radio Frequency Propagation Aspects; 7.3 Introduction to DAB Networks; 7.4 Particularities of Single frequency networks (SFN); 7.5 DAB Transmitters; 7.6 Coverage Planning7.7 Coverage Evaluation and Monitoring of SFNs7.8 Frequency Management; 8 The Receiving Side; 8.1 General; 8.2 RF Front-end; 8.3 Digital Baseband Processing; 8.4 Audio Decoder; 8.5 Interfaces; 8.6 Integrated Circuits for DAB; 8.7 Receiver Overview; 8.8 Operating a DAB Receiver - the Human-Machine Interface; Appendices; Appendix 1: DAB Parameters for Modes I, II, III and IV; Appendix 2: Digital Radio (DAB): Status of Introduction World-wide; Appendix 3: Frequencies for Terrestrial and Satellite DAB Transmission; Bibliography; Standards and Related Documents; Publications; Further ReadingInternet LinksIndexNow the standardisation work of DAB (Digital Audio Broadcasting) system is finished many broadcast organisations, network providers and receiver manufacturers in European countries and outside of Europe (for example Canada and the Far East) will be installing DAB broadcast services as pilot projects or public services. In addition some value added services (data and video services) are under development or have already started as pilot projects. The new digital broadcast system DAB distinguishes itself from existing conventional broadcast systems, and the various new international standards Digital audio broadcastingDigital communicationsDigital audio broadcasting.Digital communications.621.384Hoeg Wolfgang866638Lauterbach Thomas960337MiAaPQMiAaPQMiAaPQBOOK9910143227503321Digital audio broadcasting2176811UNINA06583nam 2201717z- 450 991055750590332120210501(CKB)5400000000044497(oapen)https://directory.doabooks.org/handle/20.500.12854/68521(oapen)doab68521(EXLCZ)99540000000004449720202105d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierFlavonoids and Their Disease Prevention and Treatment PotentialBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 online resource (346 p.)3-0365-0000-6 3-0365-0001-4 Flavonoids are ubiquitously present in plant-based foods and natural health products. The molecule of flavonoids is characterized by a 15-carbon skeleton of C6-C3-C6, with the different structural configuration of subclasses. The major subclasses of flavonoids with health-promotional properties are the flavanols or catechins (e.g., epigallocatechin 3-gallate from green tea), the flavones (e.g., apigenin from celery), the flavonols (e.g., quercetin glycosides from apples, berries, and onion), the flavanones (e.g., naringenin from citrus), the anthocyanins (e.g., cyanidin-3-O-glucoside from berries), and the isoflavones (e.g., genistein from soya beans). Scientific evidence has strongly shown that regular intake of dietary flavonoids in efficacious amounts reduces the risk of oxidative stress- and chronic inflammation-mediated pathogenesis of human diseases such as cardiovascular disease, certain cancers, and neurological disorders. The physiological benefits of dietary flavonoids have been demonstrated to be due to multiple mechanisms of action, including regulating redox homeostasis, epigenetic regulations, activation of survival genes and signaling pathways, regulation of mitochondrial function and bioenergetics, and modulation of inflammation response. The role of flavonoids on gut microbiota and the impact of microbial metabolites of flavonoids on optimal health has begun to unravel. The complex physiological modulations of flavonoid molecules are due to their structural diversity. However, some flavonoids are not absorbed well, and their bioavailability could be enhanced through structural modifications and applications of nanotechnology, such as encapsulation. This Special Issue consists of four review articles on flavonoids and 15 original research articles, which cover the latest findings on the role of dietary flavonoids and their derivatives in disease prevention and treatment.HumanitiesbicsscSocial interactionbicsscA-type proanthocyanidinsAcer okamotoanumafzelinaglyconsallodyniaamoebiasisanalgesiaangiogenesisanthocyaninanti-aging activityantiadhesive activityanticancer activityantioxidant activityantiprotozoal agentsapigeninapoptosisaspirinbacopaside Ibacoside Abacterial sepsisbioguided isolationblack rice cyanidin-3-O-glucosideCAM assaycancercancer chemopreventioncancer preventioncancer stem cellscanine cancer cell linescarcinogenesisCD44+/CD24−CDKscell cyclecell morphologycell proliferationchalconeschronological lifespancitruscitrus flavonoidsclinical trialscognitioncolorectal cancerCOVID-19cranberryCVDcytokinesdefatted pitaya seedDNA damagedyslipidemiaextractionflavan-3-olsflavonesflavonoidflavonoid contentflavonoidsflavonoids and their derivativesfoods for healthgene and protein regulatory networksglycosideshuman colon cancer cellshydroxybenzoic acidshyperalgesiahypersensitivityIKKβ, inflammatory cytokinesIL-1βIL-6IL-8in-vivo angiogenesisinfectious diseasesinflammationisoquercitrinisorhamnetinlung cancerluteolinmacrophagesmembrane PUFAs profilememory extinctionMexican oreganomicemicrobiomemicrogliamolecular mechanismsn/anatural productsneohesperidinneuroprotectionNF-kBNF-κBnon-flavonoidsobesitypassive avoidance testphenolic contentphenolic metabolitesphytochemicalsphytomedicinepro-inflammatory cytokinesprobioticsquercitrinresponse surface methodologySARSARS-COV-2smart nanoparticlesStat3synergistic effecttangeretinTNF-αtobacco-specific nitrosaminetoll-like receptor 4UPECurinary tract infectionsuropathogenic Escherichia coliUTIsvasorelaxationwood sterolsHumanitiesSocial interactionRupasinghe H.P. Vasanthaedt1283178Rupasinghe H.P. VasanthaothBOOK9910557505903321Flavonoids and Their Disease Prevention and Treatment Potential3018931UNINA